Financials
- Market Capitalization 12.24 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-45.32
Fiyat/satışlar oranı
13.63
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 711 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 236.97 USD | -2.81% | -2.83% | +2.78% | +69.26% | 14.87 B USD | ||
| 731 | EXEL Exelixis, Inc. - Common Stock | 56.04 USD | -0.81% | -0.21% | +5.14% | +43.55% | 14.09 B USD | ||
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.30 USD | +0.33% | -4.20% | +5.96% | -22.96% | 11.88 B USD | ||
| 828 | AXSM Axsome Therapeutics, Inc. - Common Stock | 228.28 USD | -2.36% | -5.79% | -10.25% | +75.33% | 11.75 B USD |